Previous Article | Next Article 
Journal of Clinical Microbiology, July 2000, p. 2784-2787, Vol. 38, No. 7
Division of Viral and Rickettsial Diseases,
National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Atlanta, Georgia
Received 30 November 1999/Returned for modification 10 March
2000/Accepted 2 May 2000
Rotavirus strains from 964 fecal specimens collected from children
at 11 U.S. hospital laboratories from November 1997 to March 1998 and
from samples collected at 12 laboratories from November 1998 to March
1999 were typed for G and P proteins. Serotype G1 was the predominant
serotype in 1997-1998 (88%), followed by G2 (6.2%), G9 (3.3%), and
G3 (1.5%). This pattern was similar to that seen in 1998-1999: G1
(79%), G2 (15%), G9 (3.0%), G4 (1.6%), and G3 (0.3%). Novel P[9]
strains were identified in both seasons, and analysis of a
364-nucleotide fragment from gene segment 4 of one of the strains
demonstrated 97.3% nucleotide identity with the prototype P3[9],G3
strain, AU1, isolated in Japan. This is the first report of a human
AU1-like strain in the United States. These results reinforce our
initial findings that serotype G9 persists in the United States but has
not become a predominant strain and that the common serotypes G1 to G4
account for almost 90% of strains in circulation. Other uncommon
strains exist in the United States but may have been overlooked before
because of their low prevalence and the use of inadequate diagnostic tools.
Human rotavirus is the most common
etiologic agent of severe diarrhea in young children worldwide
(14). Vaccines under development hold the promise of
substantially reducing the severe disease caused by rotavirus
infection. The first vaccines have been developed to provide
specific protection against the four predominant serotypes of
rotavirus, G1 to G4 (15). Since less-common strains are in circulation, knowledge of rotavirus strains in current circulation will
aid in assessing whether candidate vaccines will protect against these
serotypes as well.
The rotavirus genome is composed of 11 segments of double-stranded RNA
located inside the core of a triple-layered protein capsid. Each gene
segment encodes a specific viral protein, of which six are structural
(VP1 to VP6) and five are nonstructural (NSP1 to NSP5) (5).
The two viral outer capsid proteins, VP4 and VP7, elicit a neutralizing
immune response, creating both serotype-specific and cross-reactive
immunity (12, 21). These proteins are also the basis of the
G (VP7 glycoprotein) and P (protease-activated
VP4 protein) serotypes. To date, 9 P serotypes and 10 G serotypes have
been identified in humans by cross-neutralization tests (5, 21a,
26, 28). Genotyping and serotyping studies indicate that only
four frequently observed neutralization antigen gene
combinations In 1996, the Centers for Disease Control and Prevention established the
National Rotavirus Strain Surveillance System to document the serotypes
in circulation before and after the implementation of a U.S. rotavirus
vaccination program (24) and to determine whether uncommon
strains not represented in the vaccine might emerge to become more
prevalent following widespread use of the vaccine in children. During
the first year of surveillance and before vaccinations began, our lab
group unexpectedly found a relatively high prevalence of serotype G9 in
4 of 10 U.S. cities (24). Together with other recent reports
of elevated rates of serotype G9 in children from India, Bangladesh,
France, Malawi, Australia, and the United Kingdom, these results raised
the possibility that serotype G9 might represent an emerging strain
that could escape vaccine-induced immunity and become more prevalent
after the start of the vaccination program in the fall of 1998 (1, 3, 3a, 22, 23, 30; M. Iturriza, J. Green, M. Ramsay, D. Brown, U. Desselberger, and J. J. Gray, Abstr. 18th Am.
Soc. Virol., abstr. W43-2, 1999).
We report here the results of 2 additional years of rotavirus strain
surveillance in the United States, including the first year of the
vaccination program (1998-1999), and compare these with the results
from the first year of surveillance.
During the U.S. rotavirus season, November to March, a total of 325 rotavirus-positive diarrhea specimens were collected from children at
11 hospital-based laboratories in the United States in 1997-1998, and
639 specimens were received from 12 collaborators in 1998-1999, using
a protocol described previously (24). In brief, each
hospital sent rotavirus-positive specimens that were confirmed to be
positive with a commercial rotavirus detection kit (Rotaclone; Meridian
Diagnostics, Inc., Cincinnati, Ohio) at the Centers for Disease Control
and Prevention. All rotavirus-positive samples were tested for
G-serotype and VP6-subgroup antigens by using a monoclonal antibody
(MAb)-based enzyme immunoassay (EIA) (2, 11, 27). Samples
that could not be G serotyped by EIA were genotyped by reverse
transcription-PCR (RT-PCR) (4, 9). Using multiplex
seminested RT-PCR (6), we P genotyped a subset of G1 strains
(41% in 1998 and 32% in 1999) because they were very abundant. In
contrast, all P genotypes were determined for each of the less
prevalent types G2, G3, G4, and G9. Subsets of serotype G1 samples for
P genotyping were selected systematically in the database, ensuring
that at least 25% of G1 strains representative of collection dates
from each locale were analyzed. These results were then extrapolated to
provide a P genotype for 100% of the G1 strains. Classifications of P
and G types were designated in accordance with recommendations of the
Rotavirus Nomenclature Working Group (5). To confirm the P
genotype of the AU1-like strain, P[9],G3, a fragment of the VP4 gene
was sequenced by using the primer pair (con2 and con3) which amplifies
an 876-nucleotide segment in the VP8 region with methods described
previously (24).
Of the 964 rotavirus specimens examined for G and P types, five samples
represented G mixed infections and only five could not be G typed
(Table 1). Serotype G1 predominated each
year in all cities, except for Little Rock and Philadelphia in
1998-1999, at a prevalence of 50 to 100% per locale, constituting
89% of specimens in 1997-1998 and 79% of specimens in 1998-1999.
Other G types varied by location, with G2 being the second most common overall during both years (6.2 and 15% in 1997-1998 and 1998-1999, respectively); however, in Little Rock, Ark., and Philadelphia, Pa.,
type G2 was more prevalent than G1 in 1998-1999. Interestingly, strains of the novel G9 serotype were the third most prevalent in the
second (3.3%) and third (3.0%) years of surveillance. Other G
serotypes (G3 and G4) were less abundant and occurred sporadically year
to year.
0095-1137/00/$04.00+0
Surveillance of Rotavirus Strains in the United
States: Identification of Unusual Strains
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
P[8],G1; P[4],G2; P[8],G3; and P[8],G4are
common worldwide (7), although large regional variation of G
serotypes (e.g., G5 in Brazil and G9 in India) has been documented in
some developing countries (8, 23).
TABLE 1.
G types identified in U.S. rotavirus strain surveillance
years 1997-1998 and 1998-1999a
During 3 years of surveillance, 1,316 rotavirus strains could be
classified as 4 common and 6 uncommon serotypes, excluding nontypeables
and mixed infections (Table 2).
Consequently, the four strains that are common globally (P[8],G1;
P[8],G3; P[8],G4; and P[4],G2) represented almost 90% of the
total strains, with some annual variability. The remaining 10.3%
of strains were characterized as P[4],G1; P[6],G1;
P[6],G9; P[8],G2; P[8],G9; P[9],G3; G and P mixed
infections; and nontypeables. A number of G9 strains were found each
year in addition to single strains of those mentioned above. The P[9]
strains (long E-type and subgroup-I antigens) mentioned here were
originally isolated in Japan (20) and to our knowledge are
the first identified in the United States. On the basis of our
preliminary findings in 1998-1999, the period after vaccination began,
no marked difference was identified in the pattern of rotavirus strain
prevalence for that year.
|
The most intriguing result for the 1996-1997 rotavirus season was the
presence of serotype G9 in the United States at a frequency of 7.7%,
making it the fourth most-prevalent G type for that year (Table
3). Prior to 1996, only one G9 strain had
been isolated in the United States despite much screening,
and that was reported 13 years ago (1a). Since
the first year of surveillance, G9 strains have not disappeared but
have persisted as two variants, P[8],G9 and P[6],G9, at a decreased
prevalence of 3.3% in 1997-1998 and 3.0% in 1998-1999. G9 strains
have been identified at 10 of the 13 locales surveyed and were detected
in Omaha during each consecutive year of surveillance. Our results are
consistent with works in progress in several laboratories where G9
strains have been isolated in the United States in recent years
(F. E. Campos, P. Azimi, M. A. Staat, T. Berke, L. J. Jackson, D. I. Bernstein, D. Ward, L. K. Pickering, and
D. O. Matson, Abstr. 37th Infect. Dis. Soc. Am. (IDSA), abstr.
702, 1999; V. Jain, H. F. Clark, P. Dennehy, K. Zangwill,
C. D. Kirkwood, R. I. Glass, and J. R. Gentsch, Abstr.
18th Amer. Soc. Virol., abstr. W43-4, 1999). The serotype P[6],G9
strains identified during the 3 years of surveillance had a short
electropherotype by polyacrylamide gel electrophoresis and VP6
subgroup-I antigens and were distinct from serotype P[8],G9, which
had a long electropherotype and VP6 subgroup-II antigens. In contrast
to the findings of Ramachandran et al. (24), the serotype G9
strains found in 1997-1999 did not react with MAb F45:8 in EIA,
suggesting either some antigenic drift in the G9 strains or the weak
reactivity of the F45:8 MAb (16). RT-PCR, using G9 specific
primers, provided the sole means to identify G9 strains (4).
|
In conclusion, as part of the National Rotavirus Strain Surveillance System, over 1,300 rotavirus strains from 3 consecutive years of rotavirus surveillance have been typed, and only 10 specimens were found to be G nontypeable. The common G1 to G4 strains represented the majority of the strains each year; however, some unusual strains were identified as well. It is possible that rare strains were detected because of increased sample size and improved diagnostics for rotavirus characterization. Prior to this study and three reports in the last year (24; Jain et al., Abstr. 18th Amer. Soc. Virol.; Campos et al., Abstr. 37th IDSA), only four G serotypes were identified in the United States, with the exception of a single G9 isolate found in Philadelphia in 1983 (1a, 10, 19, 25); we have now identified a fifth serotype, G9, that appears to be endemic in U.S. children at an average prevalence of 4.3%. Overall, we can detect 10 P and G type combinations, although 6 of these are infrequently identified but nevertheless present. These results extend previous findings demonstrating the presence of rotavirus with uncommon P and G combinations in the United States (18, 25). Rotavirus mixed infections also existed but at a lower rate than levels found in India and Brazil. Since mixed infections provide the means for natural reassortment and virus evolution, it is likely that in the United States, virus evolution is slower than in countries like India and Brazil, where mixed infections are more common (17, 23, 29; V. Gouvea and N. Santos, Letter, Vaccine 17:1291-1292, 1999).
This study has several limitations, including the small number of sites surveyed, the finite number of strains typed, and the number of genes (VP7 and VP4) used to characterize rotavirus strains. In addition, specimens were collected only during the rotavirus season, November to March. Furthermore, if MAb EIAs were incorporated in this project as the sole means to characterize rotavirus G types, 30 to 40% of specimens would have been considered nontypeable, in agreement with results from other studies (13, 24, 30; Campos et al., Abstr. 37th IDSA). RT-PCR was essential to fully characterize this collection. The practice in the past of typing only one gene product, VP7, could explain the previous failure to discover the rare strains identified here; our findings should encourage other reference laboratories to examine more than one gene product. Continued surveillance is planned to monitor changes in strain prevalence to better understand virus evolution and the shifting trends of strain patterns over time, which could affect future vaccine strategies that are predicated on the development of serotype-specific immunity to the globally common G serotypes.
| |
ACKNOWLEDGMENTS |
|---|
We thank John O'Connor for his editorial contribution and Harry Greenberg, Ruth Bishop, Barbara Coulson, Shozo Urasawa, and Koki Taniguchi for providing MAbs.
D.D. Griffin is supported in part by the Oak Ridge Institute for Science and Education. C.D. Kirkwood was supported by the Atlanta Research and Education Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Viral Gastroenteritis Section MS G04, Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, Atlanta, GA 30333. Phone: (404) 639-3628. Fax: (404) 639-3645. E-mail: dkg2{at}cdc.gov.
Participants in the National Rotavirus Strain Surveillance System
include Rebecca Nelson, Arkansas Children's Hospital, Little Rock;
Michelle Hartin, Children's Hospital of San Diego, San Diego, Calif.; Christine Robinson, Children's Hospital of Denver, Denver, Colo.; Yolanda Arcilla, Medical Center of Delaware, Newark; Gayle Bloom, Clarian Health Partners, Indianapolis, Ind.; David Abel, Children's Mercy Hospital of Kansas City, Kansas City, Mo.; Gary Leonardi, Nassau County Medical Center, East Meadow, N.Y.; Paul A. Yam, Children's Memorial Hospital of Omaha, Omaha, Nebr.; DeLores Aiazzi, Washoe Medical Center of Reno, Reno, Nev.; H. Fred Clark, Children's Hospital of Philadelphia, Philadelphia, Pa.; Pam
Zapalec, Driscoll Foundation Children's Hospital of Corpus Christi,
Corpus Christi, Tex.; Charles Ash, Egleston Children's Hospital,
Atlanta, Ga.; and Kathy Dugaw, Children's Hospital and Regional
Medical Center, Seattle, Wash.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. |
Bon, F.,
C. Fromantin,
S. Aho,
P. Pothier,
E. Kohli, and The Azay Group.
2000.
G and P genotyping of rotavirus strains circulating in France over a three-year period: detection of G9 and P[6] strains at low frequencies.
J. Clin. Microbiol.
38:1681-1683 |
| 1a. |
Clark, H. F.,
Y. Hoshino,
L. M. Bell,
J. Groff,
G. Hess,
P. Bachman, and P. A. Offit.
1987.
Rotavirus isolate W161 representing a presumptive new human serotype.
J. Clin. Microbiol.
25:1757-1762 |
| 2. |
Coulson, B.,
L. E. Unicomb,
G. A. Pitson, and R. F. Bishop.
1987.
Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses.
J. Clin. Microbiol.
25:509-515 |
| 3. | Cunliffe, N. A., J. S. Gondwe, R. L. Broadhead, M. E. Molyneux, P. A. Woods, J. S. Bresee, R. I. Glass, J. R. Gentsch, and C. A. Hart. 1999. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J. Med. Virol. 57:308-312[CrossRef][Medline]. |
| 3a. | Cubitt, W. D., A. D. Steele, and M. Iturriza. 2000. Characterization of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6]. J. Med. Virol. 61:150-154[CrossRef][Medline]. |
| 4. |
Das, B. K.,
J. R. Gentsch,
H. G. Cicirello,
P. A. Woods,
A. Gupta,
M. Ramachandran,
R. Kumar,
M. K. Bhan, and R. I. Glass.
1994.
Characterization of rotavirus strains from newborns in New Delhi, India.
J. Clin. Microbiol.
32:1820-1822 |
| 5. | Estes, M. 1996. Rotaviruses and their replication, p. 1625-1655. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa. |
| 6. |
Gentsch, J. R.,
R. I. Glass,
P. Woods,
V. Gouvea,
M. Gorziglia,
J. Flores,
B. K. Das, and M. K. Bhan.
1992.
Identification of group A rotavirus gene 4 types by polymerase chain reaction.
J. Clin. Microbiol.
30:1365-1373 |
| 7. | Gentsch, J. R., P. A. Woods, M. Ramachandran, B. K. Das, J. P. Leite, A. Alfieri, R. Kumar, M. K. Bhan, and R. I. Glass. 1996. Review of G and P typing results from a global collection of strains: implications for vaccine development. J. Infect. Dis. 174(Suppl. 1):S30. |
| 8. |
Gouvea, V.,
L. de Castro,
M. do Carmo Timenetsky,
H. Greenberg, and N. Santos.
1994.
Rotavirus serotype G5 associated with diarrhea in Brazilian children.
J. Clin. Microbiol.
32:1408-1409 |
| 9. |
Gouvea, V.,
R. I. Glass,
P. Woods,
K. Taniguichi,
H. F. Clark,
B. Forrester, and Z. Y. Fang.
1990.
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.
J. Clin. Microbiol.
28:276-282 |
| 10. | Gouvea, V., M.-S. Ho, R. I. Glass, P. Woods, B. Forrester, C. Robinson, R. Ashley, M. Riepenhoff-Talty, H. F. Clark, K. Taniguchi, E. Meddix, B. McKellar, and L. Pickering. 1990. Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J. Infect. Dis. 162:362-367[Medline]. |
| 11. |
Greenberg, H.,
V. McAuliffe,
J. Valdesuso,
R. Wyatt,
J. Flores,
A. Kalica,
Y. Hoshino, and N. Singh.
1983.
Serological analysis of the subgroup protein of rotavirus using monoclonal antibodies.
Infect. Immun.
39:91-99 |
| 12. |
Hoshino, Y.,
L. J. Saif,
M. M. Sereno,
R. M. Chanock, and A. Z. Kapikian.
1988.
Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
J. Virol.
62:744-748 |
| 13. | Iturriza-Gomara, M., J. Green, D. W. G. Brown, U. Desselberger, and J. J. Gray. 1999. Comparison of specific and random priming in the reverse transcription polymerase chain reaction for genotyping group A rotaviruses. J. Virol. Methods 78:93-103[CrossRef][Medline]. |
| 14. | Kapikian, A. Z., and R. M. Chanock. 1996. Rotaviruses, p. 1657-1708. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa. |
| 15. | Kapikian, A. Z., Y. Hoshino, R. M. Chanock, and I. Perez-Schael. 1996. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J. Infect. Dis. 174(Suppl. 1):S65-S72. |
| 16. | Kirkwood, C., P. J. Masendycz, and B. S. Coulson. 1993. Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses. Virology 196:79-88[CrossRef][Medline]. |
| 17. | Leite, J. P., A. A. Alfieri, P. Woods, R. I. Glass, and J. R. Gentsch. 1996. Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis. Arch. Virol. 141:2365-2374[CrossRef][Medline]. |
| 18. | Li, B., H. F. Clark, and V. Gouvea. 1993. Nucleotide sequence of the VP4-encoding gene of an unusual human rotavirus (HCR3). Virology 196:825-830[CrossRef][Medline]. |
| 19. | Matson, D. O., M. K. Estes, J. W. Burns, H. B. Greenberg, K. Taniguchi, and S. Urasawa. 1990. Serotype variation of human group A rotaviruses in two regions of the USA. J. Infect. Dis. 162:605-614[Medline]. |
| 20. |
Nakagomi, O.,
T. Nakagomi,
Y. Hoshino,
J. Flores, and A. Z. Kapikian.
1987.
Genetic analysis of a human rotavirus that belongs to subgroup 1 but has an RNA pattern typical of subgroup II human rotaviruses.
J. Clin. Microbiol.
25:1159-1164 |
| 21. |
Offit, P. A.,
H. F. Clark,
G. Blavat, and H. B. Greenberg.
1986.
Reassortant rotaviruses containing structural proteins VP3 and VP7 from different parents induce antibodies protective against each parental serotype.
J. Virol.
60:491-496 |
| 21a. | Okada, J., T. Urasawa, N. Kobayashi, K. Taniguchi, A. Hasegawa, K. Mise, and S. Urasawa. 2000. New P serotype of group A human rotaviruses closely related to that of a porcine rotavirus. J. Med. Virol. 60:63-69[CrossRef][Medline]. |
| 22. |
Palombo, E. A.,
P. J. Masendycz,
H. C. Bugg,
N. Bogdanovic-Sakran,
G. L. Barnes, and R. F. Bishop.
2000.
Emergence of serotype G9 human rotaviruses in Australia.
J. Clin. Microbiol.
38:1305-1306 |
| 23. | Ramachandran, M., B. K. Das, A. Vij, R. Kumar, S. S. Bhambal, N. Kesari, H. Rawat, L. Bahl, S. Thakur, P. A. Woods, R. I. Glass, M. K. Bhan, and J. R. Gentsch. 1996. Unusual diversity of human rotavirus G and P genotypes in India. J. Clin. Microbiol. 34:436-439[Abstract]. |
| 24. |
Ramachandran, M.,
J. R. Gentsch,
U. D. Parashar,
S. Jin,
P. A. Woods,
J. L. Holmes,
C. D. Kirkwood,
R. F. Bishop,
H. B. Greenberg,
S. Urasawa,
G. Gerna,
B. S. Coulson,
K. Taniguchi,
J. S. Bresee,
R. I. Glass, and The National Rotavirus Strain Surveillance System Collaborating Laboratories.
1998.
Detection and characterization of novel rotavirus strains in the United States.
J. Clin. Microbiol.
36:3223-3229 |
| 25. |
Santos, N.,
M. Riepenhoff-Talty,
H. F. Clark,
P. Offit, and V. Gouvea.
1994.
VP4 genotyping of human rotavirus in the United States.
J. Clin. Microbiol.
32:205-208 |
| 26. | Sereno, M. M., and M. I. Gorziglia. 1994. The outer capsid protein VP4 of murine rotavirus strain Eb represents a tentative new P type. Virology 199:500-504[CrossRef][Medline]. |
| 27. | Taniguchi, K., T. Urasawa, Y. Morita, H. B. Greenberg, and S. Urasawa. 1987. Direct serotyping of human rotavirus in stools using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J. Infect. Dis. 155:1159-1166[Medline]. |
| 28. | Timenetsky, M. do C., V. Gouvea, N. Santos, R. C. Carmona, and Y. Hoshino. 1997. A novel human rotavirus serotype with dual G5-G11 specificity. J. Gen. Virol. 78(Part 6):1373-1378[Abstract]. |
| 29. |
Timenetsky, M. do C.,
N. Santos, and V. Gouvea.
1994.
Survey of rotavirus G and P types associated with human gastroenteritis in Sao Paulo, Brazil, from 1986 to 1992.
J. Clin. Microbiol.
32:2622-2624 |
| 30. |
Unicomb, L. E.,
G. Podder,
J. R. Gentsch,
P. A. Woods,
K. Z. Hasan,
A. S. G. Faruque,
M. J. Albert, and R. I. Glass.
1999.
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.
J. Clin. Microbiol.
37:1885-1891 |
Journal of Clinical Microbiology, July 2000, p. 2784-2787, Vol. 38, No. 7
0095-1137/00/$04.00+0
This article has been cited by other articles:
-
Bourdett-Stanziola, L., Jimenez, C., Ortega-Barria, E.
(2008). Diversity of Human Rotavirus G and P Genotypes in Panama, Costa Rica, and the Dominican Republic. Am J Trop Med Hyg
79: 921-924
[Abstract] [Full Text] -
Payne, D. C., Staat, M. A., Edwards, K. M., Szilagyi, P. G., Gentsch, J. R., Stockman, L. J., Curns, A. T., Griffin, M., Weinberg, G. A., Hall, C. B., Fairbrother, G., Alexander, J., Parashar, U. D.
(2008). Active, Population-Based Surveillance for Severe Rotavirus Gastroenteritis in Children in the United States. Pediatrics
122: 1235-1243
[Abstract] [Full Text] -
Heiman, E. M., McDonald, S. M., Barro, M., Taraporewala, Z. F., Bar-Magen, T., Patton, J. T.
(2008). Group A Human Rotavirus Genomics: Evidence that Gene Constellations Are Influenced by Viral Protein Interactions. J. Virol.
82: 11106-11116
[Abstract] [Full Text] -
Santos, N., Honma, S., Timenetsky, M. d. C. S. T., Linhares, A. C., Ushijima, H., Armah, G. E., Gentsch, J. R., Hoshino, Y.
(2008). Development of a Microtiter Plate Hybridization-Based PCR-Enzyme-Linked Immunosorbent Assay for Identification of Clinically Relevant Human Group A Rotavirus G and P Genotypes. J. Clin. Microbiol.
46: 462-469
[Abstract] [Full Text] -
Duan, Z.-J., Li, D.-D., Zhang, Q., Liu, N., Huang, C.-P., Jiang, X., Jiang, B., Glass, R., Steele, D., Tang, J.-Y., Wang, Z.-S., Fang, Z.-Y.
(2007). Novel Human Rotavirus of Genotype G5P[6] Identified in a Stool Specimen from a Chinese Girl with Diarrhea. J. Clin. Microbiol.
45: 1614-1617
[Abstract] [Full Text] -
Uchida, R., Pandey, B. D., Sherchand, J. B., Ahmed, K., Yokoo, M., Nakagomi, T., Cuevas, L. E., Cunliffe, N. A., Hart, C. A., Nakagomi, O.
(2006). Molecular Epidemiology of Rotavirus Diarrhea among Children and Adults in Nepal: Detection of G12 Strains with P[6] or P[8] and a G11P[25] Strain.. J. Clin. Microbiol.
44: 3499-3505
[Abstract] [Full Text] -
Castello, A. A., Arguelles, M. H., Rota, R. P., Olthoff, A., Jiang, B., Glass, R. I., Gentsch, J. R., Glikmann, G.
(2006). Molecular Epidemiology of Group A Rotavirus Diarrhea among Children in Buenos Aires, Argentina, from 1999 to 2003 and Emergence of the Infrequent Genotype G12.. J. Clin. Microbiol.
44: 2046-2050
[Abstract] [Full Text] -
Ruiz-Palacios, G. M., Perez-Schael, I., Velazquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., Cervantes, Y., Linhares, A. C., Lopez, P., Macias-Parra, M., Ortega-Barria, E., Richardson, V., Rivera-Medina, D. M., Rivera, L., Salinas, B., Pavia-Ruz, N., Salmeron, J., Ruttimann, R., Tinoco, J. C., Rubio, P., Nunez, E., Guerrero, M. L., Yarzabal, J. P., Damaso, S., Tornieporth, N., Saez-Llorens, X., Vergara, R. F., Vesikari, T., Bouckenooghe, A., Clemens, R., De Vos, B., O'Ryan, M., the Human Rotavirus Vaccine Study Group,
(2006). Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis. NEJM
354: 11-22
[Abstract] [Full Text] -
Banyai, K., Gentsch, J. R., Schipp, R., Jakab, F., Bene, J., Melegh, B., Glass, R. I., Szucs, G.
(2004). Molecular epidemiology of human P[8],G9 rotaviruses in Hungary between 1998 and 2001. J Med Microbiol
53: 791-801
[Abstract] [Full Text] -
Banyai, K., Gentsch, J. R., Glass, R. I., Uj, M., Mihaly, I., Szucs, G.
(2004). Eight-Year Survey of Human Rotavirus Strains Demonstrates Circulation of Unusual G and P Types in Hungary. J. Clin. Microbiol.
42: 393-397
[Abstract] [Full Text] -
Wakuda, M., Nagashima, S., Kobayashi, N., Pongsuwanna, Y., Taniguchi, K.
(2003). Serologic and Genomic Characterization of a G12 Human Rotavirus in Thailand. J. Clin. Microbiol.
41: 5764-5769
[Abstract] [Full Text] -
Ranshing, S. S., Kelkar, S. D.
(2003). Isolation and Characterization of Dually Reactive Strains of Group A Rotavirus from Hospitalized Children. J. Clin. Microbiol.
41: 5267-5269
[Abstract] [Full Text] -
Kirkwood, C., Bogdanovic-Sakran, N., Palombo, E., Masendycz, P., Bugg, H., Barnes, G., Bishop, R.
(2003). Genetic and Antigenic Characterization of Rotavirus Serotype G9 Strains Isolated in Australia between 1997 and 2001. J. Clin. Microbiol.
41: 3649-3654
[Abstract] [Full Text] -
Villena, C., El-Senousy, W. M., Abad, F. X., Pinto, R. M., Bosch, A.
(2003). Group A Rotavirus in Sewage Samples from Barcelona and Cairo: Emergence of Unusual Genotypes. Appl. Environ. Microbiol.
69: 3919-3923
[Abstract] [Full Text] -
Laird, A. R., Gentsch, J. R., Nakagomi, T., Nakagomi, O., Glass, R. I.
(2003). Characterization of Serotype G9 Rotavirus Strains Isolated in the United States and India from 1993 to 2001. J. Clin. Microbiol.
41: 3100-3111
[Abstract] [Full Text] -
Santos, N., Soares, C. C., Volotao, E. M., Albuquerque, M. C. M., Hoshino, Y.
(2003). Surveillance of Rotavirus Strains in Rio de Janeiro, Brazil, from 1997 to 1999. J. Clin. Microbiol.
41: 3399-3402
[Abstract] [Full Text] -
Abdel-Haq, N. M., Thomas, R. A., Asmar, B. I., Zacharova, V., Lyman, W. D.
(2003). Increased Prevalence of G1P[4] Genotype among Children with Rotavirus-Associated Gastroenteritis in Metropolitan Detroit. J. Clin. Microbiol.
41: 2680-2682
[Abstract] [Full Text] -
Rosa e Silva, M. L., Pires de Carvalho, I., Gouvea, V.
(2002). 1998-1999 Rotavirus Seasons in Juiz de Fora, Minas Gerais, Brazil: Detection of an Unusual G3P[4] Epidemic Strain. J. Clin. Microbiol.
40: 2837-2842
[Abstract] [Full Text] -
Pongsuwanna, Y., Guntapong, R., Chiwakul, M., Tacharoenmuang, R., Onvimala, N., Wakuda, M., Kobayashi, N., Taniguchi, K.
(2002). Detection of a Human Rotavirus with G12 and P[9] Specificity in Thailand. J. Clin. Microbiol.
40: 1390-1394
[Abstract] [Full Text] -
Bok, K., Palacios, G., Sijvarger, K., Matson, D., Gomez, J.
(2001). Emergence of G9 P[6] Human Rotaviruses in Argentina: Phylogenetic Relationships among G9 Strains. J. Clin. Microbiol.
39: 4020-4025
[Abstract] [Full Text] -
Jain, V., Das, B. K., Bhan, M. K., Glass, R. I., Gentsch, J. R., Indian Strain Surveillance Collaborating Laborator,
(2001). Great Diversity of Group A Rotavirus Strains and High Prevalence of Mixed Rotavirus Infections in India. J. Clin. Microbiol.
39: 3524-3529
[Abstract] [Full Text] -
Araújo, I. T., Ferreira, M. S. R., Fialho, A. M., Assis, R. M., Cruz, C. M., Rocha, M., Leite, J. P. G.
(2001). Rotavirus Genotypes P[4]G9, P[6]G9, and P[8]G9 in Hospitalized Children with Acute Gastroenteritis in Rio de Janeiro, Brazil. J. Clin. Microbiol.
39: 1999-2001
[Abstract] [Full Text] -
Iturriza-Gómara, M., Isherwood, B., Desselberger, U., Gray, J.
(2001). Reassortment In Vivo: Driving Force for Diversity of Human Rotavirus Strains Isolated in the United Kingdom between 1995 and 1999. J. Virol.
75: 3696-3705
[Abstract] [Full Text] -
Santos, N., Volotão, E. M., Soares, C. C., Albuquerque, M. C. M., da Silva, F. M., de Carvalho, T. R. B., Pereira, C. F. A., Chizhikov, V., Hoshino, Y.
(2001). Rotavirus Strains Bearing Genotype G9 or P[9] Recovered from Brazilian Children with Diarrhea from 1997 to 1999. J. Clin. Microbiol.
39: 1157-1160
[Abstract] [Full Text] -
Iturriza-Gómara, M., Green, J., Brown, D. W. G., Ramsay, M., Desselberger, U., Gray, J. J.
(2000). Molecular Epidemiology of Human Group A Rotavirus Infections in the United Kingdom between 1995 and 1998. J. Clin. Microbiol.
38: 4394-4401
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»